In addition to tarring/gzipping the actual documents, AS2 submissions must include the following attributes in their AS2 headers. The additional information is comprised of:
FDA submissions Type
FdaSubmissionType: Abbreviated New Drug (add submission type information)
Center Name
FdaCenter: CDER (add Center information)
The Mime Headers are to be located in the outermost MIME wrapper and will appear as follows:
X-Cyclone-Metadata-FdaSubmissionType: Abbreviated New Drug
X-Cyclone-Metadata-FdaCenter: CDER
The following example represents how the standard AS2 mime header should appear after appending the Center and SubmissionType attributes and upon and presented at the FDA ESG.
Message-ID: <1115406057162.328983@WIN2K3-ESX6>
Date: Fri, 06 May 2005 19:00:57 GMT
From: esx6
Mime-Version: 1.0
Content-Type: application/pkcs7-mime; smime-type=enveloped-data;
name=smime.p7m
Content-Transfer-Encoding: binary
Content-Disposition: attachment; filename=smime.p7m
Disposition-Notification-To: esx6
Disposition-Notification-Options: signed-receipt-protocol=optional,
pkcs7-signature; signed-receipt-micalg=optional, sha1
AS2-Version: 1.1
AS2-To: db-as2
AS2-From: esx6-as2
X-Cyclone-Metadata-FdaSubmissionType: EANDA
X-Cyclone-Metadata-FdaCenter: CDER
Content-Length: 3607
This information must be included in the outermost portion of the outermost MIME wrapper.
The table below indicates the allowable attribute values for each FDA Center destination:
Table G‑1: Allowable Center Attribute Values
|
Center Destination |
Allowed Attribute Values |
|
CBER |
AERS AERS Attachments EBLA ECTD EIDE EIND eDMF Promotional_Material Lot_Distribution_Data |
|
CDER |
AERS AERS Attachements EANDA EBLA ECTD ENDA EIND |
|
CDRH |
Adverse Events Electronic Submissions |
|
CVM |
Electronic_Submissions |